Navigation Links
Aribex Launches NOMAD Pro 2 in US
Date:4/11/2013

t, more so with our products that are easily carried from operatory to operatory," said Kaufman. "The NOMAD Pro 2 will stand up to repetitive antiseptic and cross-contamination control."

The NOMAD Pro 2 is not an entirely new product. "We kept all of the great features of the Pro and incorporated them into the Pro 2," Kaufman said. "Our customers love the lightweight design and its over-the-top ease-of-use. They love to buy one NOMAD to cover multiple operatories. They love using the most state-of-the-art technology that works with digital, phosphor, and film receptors. They especially enjoy taking it anywhere they need to go."

The Pro 2 weighs just 5.5 lbs/2.5 kg for easy use and delivers a lower-dosage exposure than some wall-mounted systems. True to its historical commitment to keeping the dose as low as reasonably achievable and providing safety for both the operator and patient, Aribex continues to use its proprietary shielding compound and backscatter shield to render the NOMAD just as safe, and in some instances, safer than traditional wall-hung intra-oral X-ray devices, as validated by more than 30 independent studies and evaluations.

For existing practices with aging equipment that needs to be replaced, the NOMAD Pro 2 is a value-added option. "Even if an office needs to replace just one wall-mounted intra-oral device, the NOMAD opens up opportunities to improve the entire operatory workflow, not to mention the long-term solution it provides for future replacement needs," Kaufman said.

"What we're seeing is a sophisticated paradigm shift, or even a complete evolution, to the new and improved way of taking intra-oral radiographs," said Kaufman. "We feel fortunate to be a leader in this movement with almost 12,000 devices now in use, and we look forward to showing dental professionals throughout the US how the NOMAD Pro 2 enhancements will further evolve intra-oral imaging."

Since its 2008 introduction, the NOMAD Pro has gr
'/>"/>

SOURCE Aribex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aribex Reaches Major Milestone, Builds 10,000th NOMAD Handheld X-ray
2. Aribex Donates 10,000th NOMAD Handheld X-ray to CMDA
3. Aribex Recognized For Growth and Quality
4. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
5. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
6. Mylan Launches Generic Version of Zyprexa® Tablets
7. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
8. American Academy of Family Physicians Foundation Launches Cities for Life
9. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Massachusetts General Hospital (MGH), the Broad ... announced today that they have launched a strategic ... targets and develop novel therapies for inflammatory bowel ... worldwide. The MGH-Broad-Amgen collaboration brings together scientists with ...
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
(Date:1/15/2014)... 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ECTE ... CGM System as a non-invasive, wireless continuous glucose monitoring ... Executive Chairman and Interim CEO of Echo Therapeutics, will ... Equity Conference. Mr. Doman will make ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Hill-Rom Holdings, Inc. (NYSE: HRC ) will release ... 2011.  The company will host a webcast the following morning ... Earnings Release:   Hill-Rom,s Fiscal 2011 Third Quarter ... be issued to the public after the close of the ...
... 2011 U.S. Senators Jerry Moran ... established the first-ever Senate Community Pharmacy Caucus, an effort ... (NCPA). (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO) The ... pharmacy issues while serving as a clearinghouse of ideas ...
Cached Medicine Technology:Hill-Rom Holdings, Inc. Hosts Fiscal 2011 Third Quarter Earnings Webcast 2NCPA Applauds Formation of Senate Community Pharmacy Caucus by Senators Jerry Moran and Jon Tester 2NCPA Applauds Formation of Senate Community Pharmacy Caucus by Senators Jerry Moran and Jon Tester 3
(Date:4/16/2014)... , While it is well known that fertility treatments ... and that multiples are at elevated risk of premature ... in Fertility and Sterility . The ... can reduce the odds of multiple births and prematurity, ...
(Date:4/15/2014)... decades-old medical mystery and in the process have found a ... about 1.5 million people a year. The researchers say they now ... has been in use for more than 50 years even ... is to the microbes it attacks. , A report ...
(Date:4/14/2014)... advances have been made in chemotherapy over the past ... healthy tissues continues to be a major challenge. ... delivery, including the use of nanocarriers, or capsules, that ... in the body. , The catch? These carriers are ...
(Date:4/14/2014)... American Associations for Dental Research (IADR/AADR) have published a ... and Craniofacial Manifestations." The complete review by researchers Sunday ... Collins, Brian L. Foster, Rachel I. Gafni, Janice S. ... Timothy Wright is published in the OnlineFirst portion of ...
(Date:4/14/2014)... treatment decisions leaves cancer patients feeling more satisfied with ... the experience, researchers from the Perelman School of ... the journal Cancer . , In a study ... MD , an associate professor in the department in ...
Breaking Medicine News(10 mins):Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Nano shake-up 2Health News:Rare bone diseases and their dental, oral and craniofacial manifestations 2Health News:Shared decision making during radiation therapy improves patient satisfaction 2Health News:Shared decision making during radiation therapy improves patient satisfaction 3
... with CyberKnife Radiosurgery Worldwide, SUNNYVALE, Calif., Nov. ... global leader in the field of radiosurgery,today announced ... to treat more than 4,000 lung cancer patients ... patients in total have been treated,with CyberKnife radiosurgery ...
... 25% of all,cancers are due to genetic factors, patients that ... on the lookout for the early warning signs of,cancer. This ... from,both a medical and psychological prospective. Cancer does run ... Today, suggests it is misleading to think of cancer as ...
... (NYSE: SGP ) today announced that it ... Commission (FTC) regarding its,planned acquisition of Organon BioSciences ... 2007. Organon BioSciences is comprised mainly of ... health business. It also,includes Nobilon, the human vaccine ...
... of Georgia Drug Agency Approves Protocol for New Clinical ... of Bavituximab in Combination with ... Inc. (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company ... C virus (HCV) infection, today announced that its Phase ...
... following is being,issued by the National Council on Disability:, ... to December 1, 2007., WHERE:, Hyatt Regency Boston ... November 29, 2007, 8:30 a.m. - 10:00 a.m. ... Vaughn -- Introduction of Council Members, NCD staff and ...
... 16 21st Services has created its,first Medical Advisory ... an innovative approach in the life settlement industry. ... the sophistication,of its underwriting model and its life expectancy ... up of physicians from,across the country who are experts ...
Cached Medicine News:Health News:Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System 2Health News:Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System 3Health News:Genetics and Risk, This Week on Your Cancer Today(TM) 2Health News:Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V. 2Health News:Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 2Health News:Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 3Health News:Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 4Health News:National Council on Disability (NCD) Hosts Quarterly Meeting 2Health News:National Council on Disability (NCD) Hosts Quarterly Meeting 3Health News:In Progressive Move, 21st Services Forms Independent Medical Advisory Board to Study Longevity, Mortality Risk 2
De Soutter supply clean cast removal saws that are low in voltage and contain an integrated extractor system, combining state-of-the-art ergonomics with performance and durability....
The three point staple, used for valgus tibial osteotomy, is easy and quick to fit, with a compact size compared with other existing systems....
... the osteotomy staples is quite similar to the type ... inner position of the anti recoil contours and the ... There are 3 kinds of staples: 1. Straight ... staples can have 3 different widths: 20mm, 26 mm ...
A new generation of ORTHOMED S.A. fixation staples, manufactured from cobalt-chromium alloy: tried and test strength and tolerance...
Medicine Products: